AI predictions and use of genetic information: Cost-effectiveness. Secure processing environment and EHDS: Comparison. ISPOR US

Multiple new ESiOR innovations are presented during the International Society for Pharmacoeconomics and Outcomes Research (ISPOR US) main congress at Atlanta in the Unites States of America on Tuesday, May 7, 2024:
  • Use of real-world data (RWD) based machine learning model to predict Alzheimer’s disease risk – cost-effectiveness evaluation
  • Returning genetic information to sample donors with high hereditary breast and ovarian cancer risk – cost-effectiveness evaluation
  • Secure processing environments (SPEs) required by the European health data space (EHDS), including SPESiOR – comparison.

Presentations on May 7:

Let’s meet at the ISPOR or elsewhere!

Additional information, contact, and meetings at the ISPOR US:

Erkki Soini